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a r t i c l e s
The human genome contains repetitive nucleotide sequences that can expand in sequence length and cause disease. Some are in noncoding sequences (for example, C9orf72 in amyotrophic lateral sclerosis 1 , FMR1 in fragile X syndrome 2 and DMPK in muscular dystrophy type 1 (ref. 3) ) and lead to mRNAs with abnormal sequences that can form RNA aggregates or abnormal non-ATG-initiated protein-translation products 4 . Others are in coding regions and translate to expanded poly-amino acid sequences. The most well-known class arises by CAG trinucleotide-expansion mutations (that encode polyGln) in nine genes and cause a range of neurodegenerative diseases including Huntington's disease, dentatorubropallidoluysian atrophy, Kennedy's disease and several spinocerebellar ataxias 5 . PolyGln expansions beyond a range of approximately 35 glutamines, depending on the host protein, are typically associated with a gain of toxic function manifested by abnormal protein aggregation in cells upon aging 5 . Less well known are GCN trinucleotide-expansion mutations that lead to polyalanine (polyAla) expansions in proteins, which, when expanded beyond approximately 19 alanines, also cause at least nine different diseases spanning a wide range of pathologies including developmental defects and neurological disorders 6, 7 . PolyAla expansions in FOXE1 may also promote the risk for certain cancers 8, 9 .
The biophysical features of polyGln sequences and the effect of varying length above and below the disease threshold have been extensively studied [10] [11] [12] . PolyGln is initially monomeric in a disordered, heterogeneous conformation, and in longer lengths it can self-associate via rate-limiting nucleation steps (which may be initiated by the formation of altered monomer conformations and/or small oligomers), thus ultimately forming amyloid-like fibrils rich in β-sheets 10, 13 . Aggregation rates positively correlate with glutamine length and can be affected by flanking regions [14] [15] [16] . Oligomeric intermediates to fibrils, and possibly the monomer in an altered conformation, have been postulated to underlie a gain-of-toxicity mechanism of pathogenesis 10, 11 . Indeed, small soluble 'oligomers' that form transiently as intermediates to fibrils have been postulated to have features inherently toxic to cells regardless of protein sequence 17 .
Much less is understood about the effect of polyAla expansions on disease-associated proteins that natively contain polyAla sequences. Because of the apparent similarities in mutation patterns to the polyGln-expansion diseases, polyAla, like polyGln, might promote misfolding and aggregation; indeed, this mechanism has been proposed 18 . However, this model is not entirely consistent with other studies suggesting that polyAla aggregates into α-helical structures of an amorphous nature 19 . We also have previously found that coexpression of Ala 37 and Gln 72 fusions to enhanced GFP (EGFP) (in which subscript numbers denote the number of repeated residues) in the same mammalian cell results in spatially and morphologically distinct aggregates, thus suggesting that the molecular bases for aggregation are different 20 . In addition, the expanded polyAla proteins seem to cluster into oligomers independently of whether cells have visible aggregates. As a consequence, we posited that polyAla might aggregate via a nonamyloid mechanism. We set out to define the mechanism of polyAla aggregation and how it affects disease-relevant proteins in the cellular context. Our results revealed that polyAla does not form amyloid under normal cellular conditions but instead immediately forms α-helical clusters, thus providing an explanation for how polyAla mutations may disrupt normal protein function.
RESULTS

Spontaneous clustering of long polyAla peptides in vitro
First, we investigated the aggregation kinetics of a purified model polyAla sequence appended to EGFP as a convenient tag for visual tracking and then compared its behavior to that of polyGln, which forms amyloid fibrils 10 . On the basis of previous schemes [21] [22] [23] , the polyAla and polyGln motifs were also flanked, via a TEV proteasecleavage site, with maltose-binding protein (MBP)) as a tool to sterically suppress aggregation until MBP cleavage (Fig. 1a) . After TEV cleavage, the Ala 7 and Gln 25 constructs remained soluble over an 8-d time course (Fig. 1b) . In contrast, EGFP-Gln 72 progressively formed insoluble material to completion, as anticipated for aggregation into fibrils. EGFP-Ala 37 also formed pelletable aggregates to 20% of the input protein levels.
To gain insight into the mechanism of aggregation, we investigated the oligomeric heterogeneity by using fluorescence-adapted sedimentation velocity analysis (SVA) in an analytical ultracentrifuge. SVA evaluates the real-time rate of sedimentation of (in our case) fluorescently labeled proteins under centrifugal force and allows molecular size and heterogeneity to be determined 22 . We have previously shown that EGFP-Ala 37 forms oligomeric clusters in cell lysates subjected to SVA 20 , but it remains unclear whether this is attributable to selfassociation or coaggregation with other cellular proteins. Under low gravitational force (rotor speed of 3,000 r.p.m.), which sediments only higher protein masses, there was no sedimentation for EGFP-Ala 7 ( Supplementary Fig. 1 ), consistently with an unaggregated soluble state. In contrast, 20% of the fluorescence signal EGFP-Ala 37 sedimented ( Supplementary Fig. 1 ), matching the proportion pelleted in our 8-d time-course experiment (Fig. 1b) . The sedimentation data could not be fitted to standard size-distribution models that assume noninteraction of species (for example, sedimentationcoefficient distribution (c(s)) or least-squares direct boundary modeling (ls-g*(s)) 24 ), thus suggesting nonideality because of the oligomers changing in size during the course of the experiment (on the order of hours).
We examined the oligomeric heterogeneity of the soluble pool by SVA at higher centrifugal force (rotor speed of 50,000 r.p.m.), which sedimented all remaining proteins (Supplementary Fig. 2 ). c(s) sizedistribution analysis revealed that EGFP-Ala 7 was monodisperse at s = 2.4 S (Fig. 2a) . The mass was estimated by fitting to a noninteracting discrete species model, which takes into consideration the effects of diffusion. The best-fit mass of 38 kDa was consistent with a monomer with a predicted mass of 31 kDa. The Ala 37 counterpart predominantly formed oligomers in the sedimentation-coefficient range of 5-30 S (Fig. 2a) . The Gln 25 and the Gln 72 counterparts both yielded single components with sedimentation coefficients of 2.4 S each (Fig. 2a) . This corresponded to masses of 39 and 33 kDa, respectively, values similar to the predicted monomer masses of 34 and 40 kDa (Fig. 2a) . We detected no oligomers for EGFP-Gln 72 ; instead, the monomer peak diminished after 4 d of incubation as a result of the formation of high-molecular-weight species that immediately pelleted and hence were not detectable at this centrifugal speed. This result led us to two conclusions. The first was that shorter lengths of polyAla and polyGln are intrinsically monomeric and do not aggregate. The second was that, upon expansion, polyGln aggregates via monomer recruitment to the fibrils, consistently with a nucleated mode of aggregation. Expanded polyAla instead spontaneously adopts a diverse array of higher-order oligomers.
We next examined the reversibility of polyAla association into oligomers. SVA of material diluted before sedimentation revealed partial EGFP-Ala 37 dissociation into monomers, thus indicating reversibility in EGFP-Ala 37 self-association (Fig. 2a) . We further investigated the mechanism of association by size-exclusion chromatography (SEC). After 1 d, TEV cleavage of the fusions (at 5 µM), EGFP-Ala 37 separated into monomers eluting at 17 ml (as calibrated by the EGFP-Ala 7 elution time), a major oligomeric population (low-mass oligomers) eluting at 12 ml and a shoulder of higher-mass oligomers (Fig. 2b) . Dilution of the EGFP-Ala 37 sample just before analysis by SEC led to the reappearance of a small monomer peak, a result in agreement with the SVA result showing some back-exchange to monomer (Fig. 2b) . We collected the fractions corresponding to the monomers (~0.05 µM), low-mass oligomers (~1 µM) and highmass oligomers (0.1 µM) and reran them on SEC both on the same day ( Fig. 2c) and after an additional overnight incubation (Fig. 2d) . The monomer fraction remained predominantly monomeric on the same-day rerun, but approximately half of this pool converted to oligomer after overnight incubation (Fig. 2c,d) . The low-mass oligomers contained a minor fraction of monomers in the same-day rerun, but monomers were subsequently depleted after overnight incubation. Collectively, these data suggested a mechanism by which monomers and small oligomers interconverted early in an association reaction, yet over time the oligomers converted into less-reversible forms.
PolyAla aggregates are a-helical
Although some studies have suggested that polyAla can form amyloid fibrils 25, 26 , there is also conflicting evidence suggesting that aggregates are α-helical 19 . Hence, we applied circular dichroism (CD) a r t i c l e s spectroscopy to assess the secondary structure of our polyAla and polyGln models. As anticipated on the basis of a previous study 27 , 4-d-incubated Gln 72 formed β-sheet structure after the EGFP contribution was subtracted out (Fig. 3a) . 4-d-incubated Ala 37 , in contrast, was α-helical. Electron microscopy confirmed fibrils for Gln 72 , whereas Ala 37 adopted only nonfibrillar structures, which are probably the largest aggregated states (and the small soluble oligomers that make up the bulk of the protein may be the features in the background) (Fig. 3b) . The Ala 7 and Gln 25 showed negligible net CD signal, and neither formed any aggregates detectable by electron microscopy.
Long polyAla sequences extensively self-cluster in cells
We next examined the extent of polyAla clustering in the cellular environment. First we performed SVA on lysates from human AD293 cells transfected with the EGFP-polyAla constructs, which revealed that long polyAla formed larger oligomeric states (Fig. 4a) , a result consistent with those of our previous study 20 . The sizes of the oligomers were similar to that produced from the purified counterparts in Figure 2a , thus suggesting that they were homo-oligomers. To examine this possibility, we used single molecule-imaging approaches, in which we applied diluted crude lysate to a coverslip and allowed the oligomers to nonspecifically absorb into discrete fluorescent spots. The bulk of the adsorbed species appeared as diffraction-limited spots of varying fluorescence intensity (Supplementary Fig. 3a) . Large aggregates were rare (less than one per field of view) and appeared as very bright, non-diffraction-limited objects with saturated pixel values; these objects could not be quantified and were excluded from analysis. Calibration of the imaging system via single-molecule photobleaching (Supplementary Fig. 3b ) allowed us to determine the number of EGFP molecules in each oligomer. This analysis confirmed that EGFP-Ala 7 was monomeric and that EGFP-Ala 37 (soluble) oligomers were heterogeneous and typically contained between 1 and 20 molecules (Fig. 4b) . 
a r t i c l e s
To further define the extent of the selfassociation patterns in intact cells, we devised a fluorescence resonance energy transfer (FRET) system by coexpressing two forms of each polyAla (or polyGln) construct together: one fused to Venus fluorescent protein (as the FRET donor) and one fused to mCherry (as the FRET acceptor). Visual inspection of plated cells before FRET analysis by flow cytometry indicated that approximately 5% of cells expressing the Ala 37 constructs had visible aggregates, whereas about 10% of cells with Gln 72 had visible aggregates, results similar to our previously reported findings 20 (not shown). Despite the low frequency of cells with visible aggregates, we detected a strong FRET signal in almost all polyAla 37 -expressing cells, whereas we detected no FRET in cells with the Ala 7 counterpart (Fig. 4c) . The FRET signal trailed off for the cells with the lowest levels of expression, a result consistent with selfassociation being driven in a concentration-dependent manner. In contrast, most cells expressing the Gln 72 proteins were FRET negative, consistently with most of these cells containing monomeric Gln 72 .
To further investigate whether polyAla self-association was related to the presence of visible aggregates in cells, we reanalyzed the flow cytometry data by pulse shape analysis (PulSA). PulSA can discriminate cells that have visible punctate aggregates (inclusions; i population) from those lacking visible aggregates (noninclusion; ni population) by monitoring changes in the fluorescence width and height parameters 28 . For Gln 72 , only cells with inclusions (the i population) correlated highly with those that were FRET positive, thus suggesting that Gln 72 is mostly monomeric in cells until inclusions form (Fig. 4d) . This pattern is consistent with a nucleated mechanism of aggregation driving a bimodal population of aggregation states in cells; i.e., cells contained either all aggregated polyGln or were monomer enriched. For Ala 37 , the i population was difficult to unequivocally identify, probably because of the poor abundance of cells with inclusions (<5% of cells) and the reduced sensitivity of PulSA for defining aggregate structures that are less punctate (as is the case for polyAla 20 ). Nonetheless, almost all cells in the ni population had a strong FRET signal, which indicated that homo-oligomerization occurred pervasively in each cell irrespective of visible aggregate formation. Cells coexpressing Ala and Ala 37 displayed no FRET, thus suggesting that the longer polyAla peptides do not recruit short polyAla peptides into the aggregate ( Supplementary  Fig. 4 ). In contrast, we observed some coaggregation for polyGln, a result consistent with those of prior reports showing that aggregation-prone polyGln sequences can recruit shorter, normally nonaggregating polyGln sequences into the aggregates 29 .
PolyAla expansion perturbs SOX3 and ARX oligomeric states
To determine whether expanded polyAla-mediated clustering could explain the dysfunction of endogenous disease-associated polyAla expansion mutations, we investigated two transcription factors, SRYrelated HMG-box 3 (SOX3) and aristaless related homeobox (ARX), both of which have four native polyAla tracts. Expansion of the first tract in human SOX3 from 15 to 22 or 26 alanines causes X-linked hypopituitarism 6, 30, 31 . Expansion in either of the first two tracts of human ARX (PA1 from 16 alanine repeats to beyond 18 and PA2 from 12 repeats to beyond 20) causes X-linked intellectual disability and seizures 32, 33 .
First, we used imaging to assess human SOX3 fused C terminally to EGFP and expressed in AD293 cells. Wild-type SOX3 (Ala 15 ) was restricted to the nucleus, whereas the Ala 26 mutant formed cytoplasmic puncta in approximately 50% of cells (Supplementary Fig. 5a ), consistently with previous findings 34 . We applied SVA on crude lysate from these cells to examine how polyAla expansion affected oligomeric state. We chose three parallel-run SVA regimes that we 
had previously found to enable oligomers of vastly different sizes (i.e., different sedimentation coefficients (S)) to be measured 20, 22 . Small oligomers (for example, monomers up to approximately 10-to 20-mers; ~1-200 S) require assay at high centrifugal force (50,000 r.p.m.), whereas larger complexes (~200-1,500 S) require low centrifugal force (3,000 r.p.m.). Very large aggregates (with a sedimentation coefficient greater than ~1,500 S) are resolvable by a further increase in solution viscosity by supplementation with 2 M sucrose.
First, we examined the largest complexes that SOX3 adopted in cells with the 3,000 r.p.m. and 2 M sucrose regime. 50% of wild-type SOX3 sedimented under these conditions, thus suggesting that a a r t i c l e s large extent of SOX3 engaged with very large structures in the cell such as the cytoskeleton, chromosomes or potentially incompletely lysed nuclei (Supplementary Fig. 6a) . The mutant had a small but significant increase in the proportion of sedimenting material under these conditions (Fig. 5a , based on proportions calculated as in Supplementary Fig. 6a) . Notably, fits to a size distribution model (fits of raw data in Supplementary Fig. 6a ) revealed a shift in the distribution of the mutant to smaller masses (Fig. 5b) . This result suggested that polyAla expansion displaced the natural ligand-bound forms of SOX3, which are very large, and promoted formation of abnormal self-aggregates that are smaller on average.
The SVA regime focusing on intermediate oligomeric sizes (~200-1,500 S) revealed the presence of fast-sedimenting material for the Ala 26 mutant that was lacking with the wild-type SOX3 ( Supplementary  Fig. 6b ). This material sedimented too rapidly (within 3 min of sedimentation) to enable size-distribution analysis; however, its abundance was measurable (Fig. 5a) , and its presence was consistent with our other data showing that polyAla promotes abnormally clustered states.
The SVA regime focusing on the smallest oligomeric sizes (~1-200 S) produced data that could not be well fitted to simple sizedistribution models, possibly because of exchange between different oligomeric states during sedimentation (which takes place over 150 min). However, analysis of the early time points of sedimentation (the first 15 min) separately from the later time points (40 min-135 min) overcame this issue. This may be because the early time points focused more on the faster-moving, larger soluble oligomers (<15 S), whereas the later time points focused on the slower-moving, smaller oligomers and the monomer (>15 S), which exchange at different rates (fits overlaying the raw data shown in Supplementary Fig. 6c ). Wild-type SOX3 formed a diverse and complex array of low-order native oligomeric states, which may include ligand-bound forms. The mutant reduced the heterogeneity of the oligomeric states, thus suggesting that polyAla expansion hindered normal SOX3 interactions (Fig. 5c) . In addition, the mutant decreased the collective abundance of loworder oligomers, as calculated by the areas under the size-distribution curves (Fig. 5a) . Collectively, these results supported the conclusion that polyAla expansion in SOX3 impaired normal ligand and selfassociations and promoted abnormally clustered states.
Our final set of experiments was to examine the influence of polyAla expansion on the clustering patterns of SOX3 and ARX in intact cells. We achieved this by measuring the granularity of polyAla-containing proteins within the nuclei of cells lacking otherwise visible aggregates.
Using fluorescence micrographs of cells stained for our proteins of interest, we defined a region of interest (ROI) that encompassed only the nucleus for each cell. We measured mean fluorescence (for protein levels) and s.d. (for variation in localized protein levels) for the pixels in each ROI, on the basis of the prediction that these parameters would correlate differently with different clustering patterns (strategy and rationale shown in Fig. 6a) . As a positive control, we used EGFP-polyAla targeted to the nucleus with a nuclear-localization sequence (NLS) ( Supplementary  Fig. 5b) . The Ala 37 variant showed a much greater s.d. than the Ala 7 variant across medium to high expression levels, thus validating this approach (Fig. 6b) . In transfected cell lines, both EGFP-SOX3 (detected by GFP fluorescence; analysis in Fig. 6c from raw data in Supplementary  Fig. 5a ) and human ARX mutants (detected by immunofluorescence; analysis in Fig. 6d from raw data in Supplementary Fig. 5c ) displayed a significant increase in s.d. relative to that of wild-type counterparts for equivalent protein levels; these results are consistent with polyAla expansions causing elevated levels of clustering.
To test whether the increase in clustering also occurred under physiological expression conditions, we performed the same imaging experiments on tissue slices of two human-ARX knock-in mouse models of ARX expansion (PA1 and PA2) 35 . ARX expression is known to be most pronounced in the ventrolateral mantle zone of the telencephalon of embryonic mice at 12.5 days post coitum (dpc) 35 . Hence we examined ARX clustering in this tissue in mutant and age-matched wild-type littermates. Concordantly with the results from transfected cells, ARX mutants displayed elevated s.d. of fluorescence relative to comparable expression levels of wild-type ARX (analysis in Fig. 6e from raw data in Supplementary Fig. 7) . Collectively, these results suggested that the abnormal clustering patterns caused by polyAla expansion underlie a general mechanism for the displacement of normal protein functionality.
DISCUSSION
Our data show that the behavior of polyAla is fundamentally dissimilar to that of polyGln and that it lacks amyloid kinetics. Hence, polyAla is unlikely-with the one exception of PABPN1, which is discussed in more detail below-to lead to the mechanisms of dysfunction proposed for amyloid proteins such as 'toxic oligomers' 12, 36 . Instead, our findings suggest a simple and straightforward mechanism by which the polyAla expansions promote the inappropriate self-assembly of these sequences together with α-helical clustering (model in Fig. 7) . This process could be driven by hydrophobic and Figure 7 Schematic summarizing how extended polyAla sequences drive an abnormally clustered state with multiple effects on structure and function. In this model, extended polyAla is α-helical and drives an association into a distribution of clusters of diverse sizes. Our data in Figure 2 suggest that these clusters can initially partially dissociate into monomers but convert over time to clusters that are more stable. We propose that the abnormal clustering interferes with normal ligand interactions of the host protein, including normal self-association patterns, and can trigger targeting for degradation. For ARX and SOX3, the final reaction products are nonamyloid aggregates. For PABPN1, we propose that the α-helically driven clustered states lower the energetic barrier to amyloid-fibril nucleation, which are driven by sequences outside the polyAla stretch. (For simplicity, we have not shown the nonamyloid sequences in the diagram of the fibrils.) npg a r t i c l e s dipole couplings of the α-helices present in these oligomers, in two apparent phases. Initially, clusters may form loosely, with a degree of reversibility allowing dissociation back to monomer; over time, the oligomers restructure to become more stable. This non-native clustering could influence the function of proteins in many ways, but at the most fundamental level it would be expected to chronically interfere with normal host-protein behavior including normal ligand-binding interactions and normal modes of self-association (i.e., the depletion of 'good oligomers'). Because clustering occurs extensively for low-order oligomers, the presence of visible or pelletable aggregates would indicate only the extreme end of the deranged clustering spectrum. This was evidenced by our ARX mouse data, in which we observed no visible aggregates (Fig. 6e and Supplementary  Fig. 7 ). This is a crucial point because, apart from PABPN1 (which is discussed in more detail below), polyAla expansions do not usually result pathologically as visible protein aggregates except when proteins are highly overexpressed in cell culture 20, [37] [38] [39] [40] [41] . However, even with PABPN1 there is evidence to support this mechanism: polyAla expansion leads to loss of ligand binding capacity (ARIH2 E3 ligase) in the soluble state 42 .
Our findings reconcile a number of observations more appropriately than does an amyloid-type mechanism of aggregation. First, rather than conferring a gain-of-toxicity function, as seen in amyloid-related aggregation, most polyAla diseases confer a loss of function 5, 6 . A loss of function is a logical consequence of an induced deranged oligomeric status leading to the disruption of normal ligand interactions. Such forms may be expected to be targeted for clearance by the qualitycontrol machinery, and indeed polyAla-expanded proteins have been shown to colocalize with cellular markers of degradation (reviewed in ref. 18 ). PolyAla-based diseases are usually fully present during development and early in life, consistently with a chronic dysfunction of the host protein, whereas most amyloid diseases have age-dependent onset and progression, which is more consistent with a nucleated mode of aggregation and a gain-of-toxicity mechanism 7, 36, 40 .
PABPN1, one of the most well-studied polyAla-containing proteins, is the only one that has been shown to form amyloid fibrils in vitro [43] [44] [45] . It is also the only polyAla-expanded protein that causes a late-onset disease. We propose that PABPN1 is distinct from other polyAla-proteins because it can cluster both by polyAla's mechanism of self-association and by an independent amyloid-mediated pathway. PolyAla expansion has been previously found not to be necessary in itself to enable PABPN1 to form amyloid fibrils 44 . However, fibrillization has been proposed to be dependent in part on two proposed oligomerizing domains, thus suggesting that oligomerization helps overcome the rate-limiting step of nucleation in amyloid kinetics 46 . Such a two-step mechanism of aggregation has a precedent in other amyloid-forming proteins 47 . Our data from this study imply that under in vivo conditions, the polyAla expansion causes an initial derangement of PABPN1 by abnormally clustering PABPN1 molecules together in a manner that favors a second step of amyloid assembly (Fig. 7) . The second amyloid-assembly step would probably arise in protein domains located elsewhere in the PABPN1 sequence from the polyAla sequence 45 . Further support for this mechanism has been observed in a report of PABPN1 N-terminal-fragment amyloid fibrillization, thus indicating that polyAla expansion confers a net increase in α-helical structure; in this context, polyAla expansion enhances PABPN1 fibrillization rates 44 .
Perhaps because of the known fibrillization of PABPN1 into amyloid, previous studies have described polyAla forming amyloid fibrils 19, 25, 26 . However, these studies used experimental conditions substantially different from those in vivo, in which polyAla is α-helical. The formation of polyAla into β-sheet aggregates has been reported to occur only under high temperatures above about 55 °C or other extreme solution conditions 19, 25, 26 . At more physiological temperatures and buffer conditions, polyAla strongly favors α-helix formation 19 . Indeed, rather than preferentially adopting a β-sheet structure, polyAla has been an exemplar for α-helical structure in the study of peptides, especially in nonpolar environments, in part because alanine has the highest propensity of all amino acids to form α-helices 48, 49 . Furthermore, there is no evidence of visible aggregate formation in mice expressing Ala 26 -containing SOX3 at endogenous levels 50 , consistently with our findings in the ARX knock-in mice (Supplementary Fig. 7) . Indeed, the SOX3-mutant mice exhibit a reduction in SOX3 protein, which, given our findings, may result from the formation of abnormal soluble oligomers that are targeted for degradation. This finding is consistent with ubiquitin-proteasomeassociated clearance mechanisms proposed for other polyAlaexpanded proteins 18 . In conclusion, our findings of an alternative explanation for how α-helix-mediated clustering of proteins relates to protein dysfunction is an important step forward in efforts to understand and treat these diseases.
METhODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METhODS
Expression constructs. The mammalian polyAla and polyGln constructs were made by cloning cDNA sequences into pEGFP-C1 and pEGFP-C2 vectors, respectively. The encoded proteins are shown in Supplementary Table 1. For the bacterial constructs, cDNA sequences were cloned into pET21d(+) to express sequences shown in Supplementary Table 1. Fluorescent protein moieties were swapped by PCR-based cloning methods. SOX3 constructs, cloned into pcDNA3.1 as described previously 34 , were excised by EcoRI and cloned into the EcoR1 site of pEGFP-C2. ARX constructs were prepared by cloning ARX cDNAs into a pCMV vector with an N-terminal myc tag, as described previously 51 . For the NLS-tagged constructs, the polyAla-EGFP cDNAs were swapped into the GFP-Tag-NLS vector. This construct expresses the NLS (residues 110-135) of the SV40 large T antigen 52 . The polyAla cDNA sequences from Supplementary Table 1 were amplified by PCR with primers NheI-EGFP-NLS forward primer (5′-GCTAGCGCTACTTGTCGCC) and the AgeI-EGFP-NLS reverse (5′-ACCGGTGGGGTCTTCTACCT). The PCR product was subcloned into NheI-AgeI sites of EGFP-NLS. All constructs were sequenced for verification.
Recombinant-protein expression and purification. pET21d(+)-EGFP-polyAla or polyGln constructs were transformed into BL21(DE3) cells and cultured in LB medium with 100 µg/ml ampicillin. Cells were grown to a density of 0.6 AU and then induced overnight at 20 °C with 1 mM isopropyl β-d-1-thiogalactopyranoside. Cells were pelleted (20 min at 5,000g and 4 °C) and resuspended in ice-cold 100 mM Tris, pH 8.0, containing EDTA-free Complete protease-inhibitor cocktail (Roche). Phenylmethylsulfonyl fluoride was added to 2 mM; this was followed by lysis with the addition of hen egg-white lysozyme to 1 mg/ml. Cell lysates were stored at -20 °C overnight or longer. Lysate was thawed on ice, and benzonase (Novagen) was added to 8 U/ml. Lysate was centrifuged (30 min at 35,000g and 4 °C), and the supernatant was loaded onto a nickel-affinity column preequilibrated with 20 mM Tris, 250 mM NaCl, and 25 mM imidazole, pH 8.0. The column was washed in several column volumes of 20 mM Tris, 250 mM NaCl, 50 mM imidazole, pH 8.0, and eluted with 20 mM Tris, 250 mM NaCl, 150 mM imidazole, pH 8.0. The eluted protein was buffer-exchanged into 20 mM Tris, 150 mM NaCl, 12.5 mM imidazole, pH 7.4, with a PD-10 column (GE Healthcare). Proteins were divided into aliquots and snap-frozen in liquid nitrogen. Protein concentration was determined with an EGFP extinction-coefficient value of 56,000 M −1 cm −1 at 488 nm.
Pelleting assays. Aliquots of protein were thawed, pelleted (30 min at 22,000g and 4 °C) to remove preexisting aggregates, and diluted to 5 µM after verification of concentration. Cleavage of MBP was initiated by addition of homemade TEV protease for 20 min at room temperature, as described previously 22 . Samples (300 µL per point) were incubated at 37 °C for various time points of the time course. One portion of the samples (100 µL) was assayed for fluorescence in a plate reader for total protein yield. A second portion (150 µL) was pelleted (18,000g for 30 min at room temperature), and 100 µL of the supernatant was assayed for fluorescence as 'unaggregated' yield.
Cell culture. HEK293T and AD293 cell lines (from laboratory cultures originally obtained from ATCC) were used in this study and tested and cleared for mycoplasma. Cells were not tested for cell-line authenticity. They were maintained in Dulbecco's modified Eagle's Medium (DMEM) supplemented with 1 mM glutamine, 200 U/ml penicillin-streptomycin and 10% (v/v) FBS. Cells were cultured at 37 °C in a humidified incubator with 5% atmospheric CO 2 . For microscopy experiments, 5 × 10 4 AD293 cells were plated on poly-l-lysine-coated eight-well microslides (Ibidi) for all constructs except those involving ARX, for which 8 × 10 5 HEK293T cells were plated on six-well plates. Sedimentation velocity analysis. Protein samples and cell lysates were assayed in an XLA analytical ultracentrifuge (Beckman) equipped with a fluorescencedetection system (Aviv), as described previously 22 , at the Macromolecular Interactions Facility at the Bio21 Institute. The mammalian lysates were prepared from transfected cells, which were detached in phosphate-buffered saline (PBS) after 24 h expression with a cell scraper and lysed as described previously 22 . Data were fitted in Sedfit (http://www.analyticalultracentrifugation.com/), including size-distribution models of c(s) and ls-g*(s) and the noninteracting discrete species model 53 .
Size-exclusion chromatography. Aliquots of protein were thawed, pelleted to remove preexisting aggregates and cleaved to remove MBP as described for pelleting assays. Samples were incubated at 37 °C at 5 µM overnight. After 24-h incubation, samples were assessed by size-exclusion chromatography (SEC) at two different protein concentrations (diluted just before SEC). SEC was performed on a Superdex 200 10/300 GL column (GE Life sciences) with 20 mM Tris, 150 mM NaCl, and 12.5 mM imidazole, pH 7.4, as the running buffer with an Akta explorer FPLC (GE Life Sciences). 500 µl of sample was run with one column volume of running buffer at a flow rate of 0.5 ml/min, and 250-µl fractions were collected. The column was washed with one column volume of running buffer between each run. The fluorescence of each fraction was assessed with a CLARIOstar microplate reader (BMG Labtech; excitation, 488 nm; emission, 523 nm; bandwidth, 10 nm).
Electron microscopy. 5 µM solutions of TEV protease-treated samples were incubated at 37 °C 4 d before application onto freshly glow-discharged carbon-coated copper grids. After 1-min application, solutions were wicked with filter paper, stained with 1.5% w/v uranyl acetate, pH 4.5, for 1 min, wicked again to remove excessive liquid, and air-dried. Samples were imaged at the Bio21 Institute Advanced Microscopy Unit with an FEI Tecnai TF30 Transmission Electron Microscope operating at 200 kV. Images were recorded digitally with a Gatan US1000 2,000 × 2,000 CCD camera. Circular dichroism spectroscopy. Proteins were thawed, pelleted and cleaved from MBP as in the pelleting assay. TEV protease and MBP were removed by application through a His-trap spin column, and the eluate was assessed by SDS-PAGE to validate purity of the poly-amino acid EGFP fusions. The eluted proteins were buffer-exchanged into 20 mM sodium phosphate, 100 mM NaCl, pH 7.4, adjusted to 3.5 µM and incubated for 4 d at 37 °C. CD spectra were collected on samples in 1-mm-pathlength cuvettes on a Chirascan-plus spectrometer (Applied Photophysics). Data were converted to mean residue ellipticity and corrected for the EGFP contributions to the spectra.
Single-molecule imaging. Glass coverslips (#1.5, Warner Instruments) were cleaned in 70% (v/v) ethanol, dried at 70 °C and exposed to plasma cleaning for 10 min (Harrick Plasma). Cells were lysed as described previously 22 , and protein was diluted in imaging buffer (PBS with 0.5 mg/ml BSA, 1 mM Trolox and 10 mM cysteamine) and absorbed onto freshly cleaned coverslips for 2-3 min. Coverslips were then rinsed with imaging buffer to remove unbound protein and imaged with an inverted TIRF microscope (TILL Photonics) with Zeiss α Plan-apochromat 100× oil objective (1.46 NA), 488-nm laser line and electronmultiplying charge-coupled-device camera (Andor). Images were acquired with 50-ms exposure time. Spots in the fluorescence image were detected as local maxima, and background-corrected fluorescence intensities were extracted with in-house image-analysis software implemented with MATLAB.
Code availability. The MATLAB protocols used for the single-molecule imaging are available upon request.
FRET and PulSA. Cells were harvested 72 h after transfection by gentle pipetting in PBS. Cells were analyzed at a high flow rate in an LSRFortessa flow cytometer, equipped with 405-nm, 488-nm and 561-nm lasers (BD Biosciences). 100,000 events were collected, with a forward scatter threshold of 5,000. Data were collected in pulse height, width and area parameters for each channel. For Venus fluorescence, data were collected with a 488-nm laser and FITC filter. For mCherry fluorescence, data were collected with a 561-nm laser and PE-Texas red filter. FRET data were collected with a 488-nm laser and PI filter, and the FRET gate was set with the FRET negative controls as a reference. All flow-cytometry data were analyzed and plotted with FlowJo (http://www.flowjo. com/). For PulSA, we analyzed the data as described previously 28, 54 and used the nonaggregating protein samples to set the boundary for the ni-i gates.
Imaging. For all experiments involving cultured cells, cells were imaged 24 or 48 h after transfection. For all experiments except those involving ARX, cells were stained with 2.5 µg/ml Hoechst 33342 and fixed with 4% (w/v) paraformaldehyde in PBS for 15 min, and medium was replaced by PBS. For the SOX3, polyAla and polyGln imaging experiments, cells were imaged on a Leica TCS SP5 confocal microscope for mCherry (excitation, 561 nm; emission, 600-700 nm) and EGFP fluorescence excitation, 488 nm; emission, 500-555 nm) with a 63× objective lens. For the ARX experiments, ARX was detected by immunostaining. Cells were fixed with 3.7% (v/v) formaldehyde in PBS and permeabilized with 0.2% (v/v) Triton X-100 in PBS for 5 min. Cells were blocked with 5% (w/v) skim-milk powder in Tris-buffered saline and 0.5% (v/v) Tween (TBS-T) for 1 h at room temperature. ARX was stained with a previously described primary mouse monoclonal antibody to ARX 51 (2 µg/ml final) overnight at 4 °C. Cells were rinsed twice in high volume and then washed for 5 min at room temperature with TBS-T. Donkey anti-mouse IgG Alexa 488 (Life Technologies, A21202) secondary antibody was added at 1:1,000 dilution for 1 h at room temperature. Nuclei were counterstained and mounted for microscopy with ProLong Gold antifade reagent with DAPI (Molecular Probes, Invitrogen). Cells were imaged on a Zeiss Axio Imager M2 microscope with data collected with a 488-nm laser and FITC filter.
Mouse models of Arx. ARX GCG7/+ (BRC 03654) and ARX 432455dup/+ (BRC 03653) from RIKEN Bioresource Centre, Japan 55 were maintained on the C57BL/6 background. All experiments were approved by the Animal Ethics Committee of the University of Adelaide, Australia. Pregnant dams were euthanized by cervical dislocation, and embryos were decapitated at 12.5 dpc. Whole-mount frozen tissue from hemizygous male mice was prepared as described previously 56 and sectioned at 10 mm thick with a Microm HM505E. Frozen tissue sections were air-dried for 1 h at room temperature, and all subsequent procedures were performed in a humidified chamber to prevent drying of tissue sections. Sections were permeabilized in PBS + 0.5% (v/v) Triton for 5 min and blocked with blocking solution (10% (v/v) horse serum and 10% (w/v) BSA in PBS + 0.1% Triton) for 1 h at room temperature. Incubation with primary Arx-specific antibody (rabbit anti-ARX at 1:500 (refs. 57,58) in blocking solution was at 48 °C overnight and was followed by incubation with 1:400 donkey anti-rabbit IgG Alexa488 secondary antibody (Life Technologies, 150073) at room temperature for 4 h with washing (PBS + 0.01% (v/v) Tween 20 for 10 min three times) after each incubation. Samples were mounted with ProLong Gold Antifade Reagent with DAPI (Life Technologies). All images were analyzed with an Olympus IX81 inverted microscope equipped with CellSens 1.3 software. Immunofluorescence images were acquired with an Olympus XM10 black-and-white camera, and bright-field images were captured with an Olympus DP70 digital color camera. No statistical method was used to predetermine sample size. The experiments were not randomized and were not performed with blinding to the conditions of the experiments.
Statistics.
The P values reported in figures were calculated by two-tailed Student's t test with Prism (GraphPad) or SigmaPlot (Systat) software packages. In the case of a failed normality test (Shapiro-Wilk) or equal variance test (as indicated in the figures), the Mann-Whitney rank-sum test was also performed. For the comparisons of regressions, t tests on slopes for two independent samples were performed with the Real Statistics Resource Pack software (Release 3.5) (http:// www.real-statistics.com/) or with Prism software.
